title: [Reactivation of hepatitis B virus in chronic carriers with anti-HBe].
abstract: Thirty-eight hepatitis B virus (HBV) carriers, AgHBs and anti-HBe positive, with histologic diagnosis of chronic hepatitis have been periodically revised for three years. Three of them were homosexuals. Fourteen patients presented reactivation of viral replication characterized by the appearance in serum of HBV-DNA and an increase in transaminase levels. Only 7/27 (26%) presented spontaneous reactivation in contrast with 7/11 (64%) patients who had been treated with immunosuppression (p less than 0.05). Furthermore, in 3 cases free AgHBe was temporarily detected during reactivation. Histologic diagnosis and Knodell index were basically similar in reactivated patients and the rest. However, those who presented spontaneous reactivation presented a higher number of AgHB positive cells in liver tissue, both in nucleus and cytoplasm, than patients without reactivation, although, there were no significant differences in relation to the type of reactivation. In summary, this study suggests that immunosuppressants should not be given to HBV carriers with anti-HBe, since this would facilitate the reactivation of viral replication.
authors.affiliation: Departamento de Gastroenterología, Fundación Jiménez Díaz, Universidad Autónoma de Madrid.
authors.forename: J C
authors.initials: JC
authors.lastname: Porres
authors.forename: V
authors.initials: V
authors.lastname: Carreño
authors.forename: A
authors.initials: A
authors.lastname: Moreno
authors.forename: F J
authors.initials: FJ
authors.lastname: Bartolomé
mesh_terms: D000328:Adult; D001706:Biopsy; D005260:Female; D006514:Hepatitis B Surface Antigens / Q000032:analysis*; D006513:Hepatitis B e Antigens / Q000032:analysis*; D006521:Hepatitis, Chronic / Q000097:blood / Q000276:immunology* / Q000473:pathology; D006801:Humans; D008297:Male; D008875:Middle Aged
chemical_list: D006514:Hepatitis B Surface Antigens; D006513:Hepatitis B e Antigens
vernacular_title: Reactivación del virus B de la hepatitis en portadores crónicos con anti-HBe.